Superworth

Aveanna Healthcare AVAH

Medical - Care Facilities, Healthcare
$13.38
+0.45%
Market cap
$2.9B
PE
10.9×
1y median 21.8×
Forward PE
n/m
not a meaningful number
Price to sales
1.1×
EV/EBIT
14.6×
Revenue, 12 months
$2.6B
+20% on a year ago
Net margin
10.6%
Free cash flow yield
5.4%

Aveanna Healthcare trades at 10.9× trailing earnings, near its ten-year median. Revenue was $2.6B over the last twelve months, up 20% on a year earlier with a 11% net margin.

Charts

Financials

Income statement for AVAH, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$478M+8%$478.8M+6%$490.7M+5%$505M+7%$509M+7%$519.9M+9%$559.2M+14%$589.6M+17%$621.9M+22%$662.5M+27%$647.9M+16%$670.5M+14%
Cost of revenue$330.7M+7%$330.4M+3%$344.8M+7%$346.7M+10%$349.3M+6%$348.1M+5%$375.7M+9%$378.8M+9%$419.1M+20%$449.2M+29%$442.5M+18%$452M+19%
Gross profit$147.3M+9%$148.4M+15%$145.9M+1%$158.3M+2%$159.7M+8%$171.7M+16%$183.6M+26%$210.8M+33%$202.8M+27%$213.3M+24%$205.4M+12%$218.5M+4%
SG&A$91M+2%$87M−3%$87.9M−4%$88M−4%$88.2M−3%$88.7M+2%$91.4M+4%$90.1M+2%$95.4M+8%$97.6M+10%$95.8M+5%$97.1M+8%
−$76.4M$29.3M$22.9M+30%$37.1M−1%$34M$45.8M+56%$51.8M+127%$80M+116%$53.6M+58%$71M+55%$69.3M+34%$80M−0%
Interest expense$39.6M+39%$39.7M+17%$39.6M+10%$39.6M+4%$39.2M−1%$38.1M−4%$36.3M−8%$36M−9%$35.1M−11%$32.6M−14%$29.2M−20%$27.8M−23%
Pre-tax income−$101.8M−$31.6M−87%$1.5M$4M−84%−$27.3M−73%$26.9M$10.1M+581%$44.1M+1009%$13.4M$39.2M+46%$45M+343%$56.5M+28%
$631K−$5.9M+330%$12.7M+709%−$9.9M+1126%$15.5M+2358%−$2.2M−62%$5M−61%$17.1M−$647K−$139.5M+6114%$3.3M−33%$16.2M−6%
Net income−$102.4M−$25.7M−89%−$11.2M−65%$13.9M−46%−$42.8M−58%$29.2M$5.2M$27M+94%$14.1M$178.8M+513%$41.7M+702%$40.3M+49%
−$0.54−$0.13−90%−$0.06−65%$0.07−46%−$0.22−59%$0.15$0.03$0.13+86%$0.06$0.80+433%$0.19+533%$0.18+39%
189.1M+2%190.9M+3%192.2M+2%196.9M+4%193.4M+2%193.4M+1%206.2M+7%210.4M+7%222.2M+15%223.5M+16%222.1M+8%224.9M+7%

Gross profit: 26 periods, Q1 FY20 to Q2 FY26: not printed by the filing, worked out from its own lines.

EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 4 periods, Q4 FY20 to Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Care Facilities nearest Aveanna Healthcare's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
AVAHAveanna Healthcare$2.9B10.9×21.8×1.1×+20%10.6%
PRVAPrivia Health$2.9B107×158×1.2×+24%1.2%
MDPediatrix Medical$2.4B14.0×13.4×1.2×+1%9.0%
NHCNational Healthcare$3.7B26.5×21.4×2.4×+7%9.0%
ADUSAddus HomeCare$2.3B21.4×32.4×1.5×+16%7.1%
PGNYProgyny$2.2B31.5×55.1×1.7×+6%6.0%
OPCHOption Care Health$4.7B23.5×26.4×0.8×+6%3.7%
HCSGHealthcare Services$1.7B14.7×26.1×0.9×+4%6.6%
ARDTArdent Health$1.7B22.3×8.5×0.3×+3%1.2%
LFSTLifeStance Health$4.9B99.5×142×3.1×+20%3.2%
CONConcentra Group Holdings Parent$5B25.5×17.5×2.2×+14%8.7%
Peer median$2.6B24.5×26.3×1.4×+6%6.3%

More on Aveanna Healthcare

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Care Facilities
Sector
Healthcare

Valuation data, not investment advice. Prices as of .